GlassScriptPhysician profile
Sameer Onaly Kapasi
NPI 1831397355
$4,731.36
in general payments reported to CMS, 2019-2025
12 companies · $2,555 in 2025
The $2,555 reported for 2025 was more than what 83% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $22.89 · 2021: $15.89 · 2023: $885 · 2024: $1,110 · 2025: $2,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,788 · Travel and Lodging: $1,262 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,788.12 |
| Travel and Lodging | $1,261.59 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,679.53 | 2023-2025 | Intracept, General - Pain Management, Superion Indirect Decompression System |
| Spr Therapeutics, INC | $580.84 | 2024-2025 | Sprint Pns System |
| Hydrocision, INC. | $500.00 | 2023 | Tenjet |
| Stryker Corporation | $334.25 | 2025 | Spinejack, Mild Device Kit |
| Abbott Laboratories | $235.02 | 2023-2024 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $168.70 | 2021-2023 | Intracept |
| Allergan, INC. | $126.54 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $32.45 | 2025 | |
| Pacira Therapeutics, INC. | $22.89 | 2020 | |
| Spinal Simplicity, LLC | $20.52 | 2024 | Ha Minuteman G3-R |
| Bioventus LLC | $16.33 | 2019 | |
| Depuy Synthes Sales INC. | $14.29 | 2024 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Kapasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.